Dr. Gilbert Glady graduated from Med School in 1977 and was then a resident in onco-hematology in the university clinic for several years. After a specialization in natural medicines in Paris, he returned to the Alsace region to work as a private practitioner. Through his work and encounters, he developed interest and expertise in immunology and immunogenetics, that leaded him to nanomedicine and nanobiotechnology. He thus became in 2010 the creator of the BI(G)MED method (Bio Immune (G)ene Medicine) and director of EBMA, the European association responsible for the communication and trainings in the field of BI(G)MED. He has participated in numerous international congresses in immuno-allergology, infectiology and oncology with posters and oral presentations, and is the author of several publications on nanobiotherapy in different journals.
Title : Regulation of asthma with non-coding RNAS used in the context of a nanobiotherapy